Medical Necessity Guidelines: Experimental, Investigational or Unproven Services
Defines EmblemHealth's determination and restrictions for services, devices, procedures, supplies or drugs deemed investigational, experimental or unproven and their impact on coverage decisions for members and providers.
Removed Code effective 7/15/2026: Commercial codes 43210, 43290, 43291, 0675T, 0677T, 0679T, 0681T, 0683T, 0685T
Added New Codes effective 1/01/2026 to Commercial: 43889, 62330, multiple 6465x series, 81354, 81524, 87183, 93145-46 and many U/T codes and Q-codes
Removed Deleted Codes effective 1/01/2026: large list including Commercial codes 0033U, 0042T, 0266T-0273T, and others
Added Codes effective 2/01/2026 to Commercial: 0019M, 0392U, 0404U, 0415U, 0419U, 0423U
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.